An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B1 receptor in response to angiotensin converting enzyme inhibition

Vascular Pharmacology

Volumn 57, Issue 1, 2012, Pages 15-23

  Roy, Caroline ^a   Marceau, Emilie ^a   Gera, Lajos ^b   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Angiotensin converting enzyme; Bradykinin B1 receptor; Lipopolysaccharide; Macrophages; Smooth muscle cells

Indexed keywords

BRADYKININ B1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; UMBILICAL ARTERY; UPREGULATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENALAPRILAT; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, BRADYKININ B1; U937 CELLS; UMBILICAL ARTERIES;

EID: 84862508219     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.09.003     Document Type: Article

References (42)

1. 1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther. 1997, 280:6-15.
2. Bawolak M.T., Gera L., Morissette G., Stewart J.M., Marceau F. B-9972 (D-Arg-[Hyp3, Igl5, Oic7, Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, Igl5, D-Igl7, Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation. J. Pharmacol. Exp. Ther. 2007, 323:534-546.
3. 1 receptor and COX2, in rabbits: effects of LPS, anti-inflammatory and anti-hypertensive drugs. Regul. Pept. 2008, 146:157-168.
4. Cairrão E., Santos-Silva A.J., Alvarez E., Correia I., Verde I. Isolation and culture of human umbilical artery smooth muscle cells expressing functional calcium channels. In Vitro Cell. Dev. Biol. Anim. 2009, 45:175-184.
5. 1 receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects. Br. J. Pharmacol. 2001, 132:327-335.
6. 9]BK: influence of enalaprilat. Am. J. Physiol. 1996, 271:H1340-H1347.
7. Dixon B.S., Evanoff D., Fang W.B., Dennis M.J. Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1. Am. J. Physiol. 2002, 283:C193-C203.
8. 1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw. J. Pharmacol. Exp. Ther. 2009, 330:756-763.
9. 1 receptors for kinins. J. Pharmacol. Exp. Ther. 1991, 259:997-1003.
10. Duan Q.L., Nikpoor B., Dubé M.P., Molinaro G., Meijer I.A., Dion P., Rochefort D., Saint-Onge J., Flury L., Brown N.J., Gainer J.V., Rouleau J.L., Agostoni A., Cugno M., Simon P., Clavel P., Potier J., Wehbe B., Benarbia S., Marc-Aurèle J., Chanard J., Foroud T., Adam A., Rouleau G.A. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am. J. Hum. Genet. 2005, 77:617-626.
11. Fleming I. Signaling by the angiotensin-converting enzyme. Circ. Res. 2006, 98:887-896.
12. Fox A.J., Lalloo U.G., Belvisi M.G., Bernareggi M., Chung K.F., Barnes P.J. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat. Med. 1996, 2:814-817.
13. Frid M.G., Moiseeva E.P., Stenmark K.R. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ. Res. 1994, 75:669-681.
14. Gainer J.V., Morrow J.D., Loveland A., King D.J., Brown N.J. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N. Engl. J. Med. 1998, 339:1285-1292.
15. Germonpre P.R., Bullock G.R., Lambrecht B.N., Van De Velde V., Luyten W.H., Joos G.F., Pauwels R.A. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur. Respir. J. 1999, 14:776-782.
16. 2 receptor genes in human promonocytic cell line U937. Acta Biochim. Pol. 2009, 56:515-522.
17. Hanif K., Bid H.K., Konwar R. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition. Hypertens. Res. 2010, 33:11-21.
18. Izeboud C.A., Mocking J.A., Monshouwer M., van Miert A.S., Witkamp R.F. Participation of β-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J. Recept. Signal Transduct. Res. 1999, 19:191-202.
19. 1 receptor expression in rabbit aortic smooth muscle. Eur. J. Pharmacol. 2009, 606:233-239.
20. Koumbadinga G.A., Bawolak M.T., Marceau E., Adam A., Gera L., Marceau F. A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells. Peptides 2010, 31:1546-1554.
21. 1 receptor expression in human vascular cells. Eur. J. Pharmacol. 2010, 647:117-125.
22. 1 receptors induced by tissue injury. J. Immunol. 1998, 160:1419-1426.
23. 1 receptors for kinins. Pharmacol. Rev. 1998, 50:357-386.
24. 1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 2002, 105:627-632.
25. Minta J.O., Pambrun L. In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate. Am. J. Pathol. 1985, 119:111-126.
26. Molinaro G., Duan Q.L., Chagnon M., Moreau M.E., Simon P., Clavel P., Lavaud S., Boileau G., Rouleau G.A., Lepage Y., Adam A., Chanard J. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney Int. 2006, 70:1823-1831.
27. Moreau M.E., Dubreuil P., Molinaro G., Chagnon M., Müller-Esterl W., Lepage Y., Marceau F., Adam A. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissue: effect of ACE inhibition and inflammation. J. Pharmacol. Exp. Ther. 2005, 315:1065-1074.
28. Moreau M.E., Garbacki N., Molinaro G., Brown N.J., Marceau F., Adam A. The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 2005, 99:6-38.
29. 1 receptor in human vascular smooth muscle cells. Mol. Pharmacol. 2007, 71:949-956.
30. 1 receptor: role of receptor density and released mediators. Can. J. Physiol. Pharmacol. 2006, 84:1107-1119.
31. 1 receptors. Peptides 2008, 29:606-612.
32. 1 in human lung fibroblasts. Mol. Pharmacol. 1999, 56:325-333.
33. Pretorius M., Rosenbaum D., Vaughan D.E., Brown N.J. Angiotensin converting enzyme inhibition increases human vascular-type plasminogen activator release through endogenous bradykinin. Circulation 2003, 107:579-585.
34. Raidoo D.M., Ramsaroop R., Naidoo S., Müller-Esterl W., Bhoola K.D. Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology 1997, 36:153-160.
35. 1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H227-H237.
36. Santos R.A.S., Ferreira A.J., Simoes e Silva A.C. Recent advances in the angiotensin-converting enzyme2-angiotensin(1-7)-Mas axis. Exp. Physiol. 2010, 93:519-527.
37. Sharma U., Rhaleb N.E., Pokharel S., Harding P., Rasoul S., Peng H., Carretero O.A. Novel anti-inflammatory mechanisms of N-acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1226-H1232.
38. Snyder R.A., Kaempfer C.E., Wintroub B.U. Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G. Blood 1985, 65:176-182.
39. 2 receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 2000, 36:132-136.
40. Stadnicki A. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease. Inflamm. Bowel Dis. 2011, 17:645-654.
41. Stanton L.A., Fenhalls G., Lucas A., Gough P., Greaves D.R., Mahoney J.A., Helden P., Gordon S. Immunophenotyping of macrophages in human pulmonary tuberculosis and sarcoidosis. Int. J. Exp. Pathol. 2003, 84:289-304.
42. Tahara H., Otani S., Matsui-Yuasa I., Koyama H., Nishizawa Y., Morisawa S., Morii H. Role of putrescine in interleukin 1β production in human histiocytic lymphoma cell line U937. J. Cell. Physiol. 1991, 147:199-207.